A key mechanism pathway leading to tumor immune evasion is the interaction of the well-known immune checkpoints CD279 (programmed cell death protein 1, (PD-1), expressed on immune cells) and CD274 (programmed death ligand 1, (PD-L1), expressed on tumor cells). The gene discussed is CD274; the disease is neoplasm.